Hypertension

chronic mesenteric ischemia :: Article Creator What To Know About Mesenteric Ischemia Mesenteric ischemia, or small bowel ischemia, involves a blockage of blood flow to the small intestine. Symptoms include pain and bloating. It often results from blood clots or atherosclerosis. Mesenteric ischemia can appear suddenly (acute) or persist over time (chronic). Sudden or severe intestinal ischemia is a medical emergency. Symptoms include abdominal pain and bloating soon after eating. Any case of mesenteric ischemia needs medical help. If it happens or worsens suddenly, it is a medical emergency. Here, learn more about mesenteric ischemia, the different types, how to recognize it, and what to expect if it happens. Small bowel or mesenteric ischemia occurs when the blood vessels leading toward or away from the small intestine become fully or partly blocked. This is often due to a blood clot, but it can happen for othe

weight loss trials near me :: Article Creator Experimental Weight Loss Drug Beat Ozempic And Wegovy In Early Trial Pharmaceutical company Novo Nordisk isn't sitting on its laurels when it comes to weight loss. The Danish-based company has just revealed preliminary data suggesting that its experimental drug amycretin can help people lose even more weight than its already blockbuster drug semaglutide, the active ingredient in Ozempic and Wegovy. Even better, amycretin is taken as a pill, as opposed to the injections needed for Ozempic and Wegovy. Researchers presented the company's data on amycertin at the annual meeting of the European Association for the Study of Diabetes this week, which comes from a Phase I trial of people living with obesity. Those taking amycretin were found on average to lose 13.1% of their body weight over a 12 week period—far above the average weight loss seen in those taking a placebo and on pace to perhaps

phase 2 vaccine trial :: Article Creator Narrow-spectrum Drug Shows Promise Against C Diff Infection In Phase 2 Trial Yaroslav Astakhov/ iStock  Targeting older adults with underlying health conditions—as opposed to the general population—for respiratory syncytial virus (RSV) vaccines would reduce spending and prevent illness, according to a modeling study yesterday in the Canadian Medical Association Journal (CMAJ). The study compared the cost-effectiveness of different vaccine programs in different age groups with different medical risks.  The model considered a population of 100,000 people aged 50 years and older. Vaccine characteristics were based on RSV vaccines authorized in Canada as of May 2024, with vaccine protection assumed to last 2 years.  The cost-effectiveness threshold was $50,000 per quality-adjusted life year (QALY). Optimal in oldest adults with underlying conditions According to the study authors, without vaccination, th

hypertension case study pdf :: Article Creator Systematic Case Finding Of People With Hypertension Shared learning database Organisation: East Berkshire CCG Published date: February 2018 It was identified within East Berkshire that there were a large number of people with undiagnosed hypertension. In order to reach a diagnosis rate comparable to the best in England, a total of 13,069 people would need to be found and diagnosed. The CCG Medicines Optimisation Team (MOT) developed a strategy to support practices in finding people who either had hypertension or were at risk of developing hypertension through systematic audit. Over 12 months the audit was delivered in all 48 practices in East Berkshire. MOT Pharmacists then added people with hypertension to disease registers or referred people not yet diagnosed for diagnosis as set out in CG127 and QRISK assessment as set out in CG181. After 12 months, there was an increas

edta chelation therapy for coronary artery disease :: Article Creator EDTA Chelation Cuts Blood Lead Levels By 61 Percent In Diabetes And MI Patients, But Fails To Prevent MACE: TACT2 Trial USA: In a recent study, the TACT2 randomized clinical trial has unveiled promising results for edetate disodium-based chelation therapy in patients with a history of myocardial infarction (MI) and diabetes. The trial, which explored the efficacy of this treatment in improving cardiovascular outcomes, offers new hope for managing these high-risk patients. The study, published in JAMA, revealed that EDTA-based chelation decreased median blood lead levels by 61% from baseline in patients with diabetes and prior MI, however, it failed to reduce major adverse cardiovascular events (MACEs). Chelation therapy, which involves the administration of a chelating agent to remove heavy metals from the body, has been used in various medical treatments for decades. Ed

high bp home remedies instant :: Article Creator 7-Day High-Protein Meal Plan For High Blood Pressure, Created By A Dietitian Have high blood pressure? This high-protein meal plan can help. Reviewed by Dietitian Jessica Ball, M.S., RDReviewed by Dietitian Jessica Ball, M.S., RD For most people, blood pressure has no noticeable symptoms but that doesn't mean it shouldn't be taken seriously. Having high blood pressure, also called hypertension, increases the risk of stroke and heart disease—two leading causes of death in the United States. If you're one of the nearly 50% of adults in the United States with high blood pressure, you may be wondering what steps you can take to protect your heart. While there are many potential causes of high blood pressure, including genetics, there are lifestyle and nutrition changes that may help improve your levels. Follow this high-protein meal plan for high blood pressure to get started. How